Leading science, pioneering therapies
CRM Publications

T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides.

TitleT cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides.
Publication TypeJournal Article
Year of Publication2009
AuthorsHarkiolaki M, Holmes SL, Svendsen P, Gregersen JW, Jensen LT, McMahon R, Friese MA, van Boxel G, Etzensperger R, Tzartos JS, Kranc KR, Sainsbury S, Harlos K, Mellins ED, Palace J, Esiri MM, P van der Merwe A, E Jones Y, Fugger L
JournalImmunity
Volume30
Issue3
Pagination348-57
Date Published2009 Mar 20
ISSN1097-4180
KeywordsAnimals, Autoimmune Diseases, Bacterial Proteins, Cells, Cultured, Cerebellum, Cross Reactions, Drosophila, Escherichia coli, HLA-D Antigens, HLA-DR2 Antigen, Humans, Immunohistochemistry, Mice, Mice, Transgenic, Models, Molecular, Molecular Mimicry, Multiple Sclerosis, Peptides, Receptors, Antigen, T-Cell, Spinal Cord, T-Lymphocytes
Abstract

Environmental factors account for 75% of the risk of developing multiple sclerosis (MS). Numerous infections have been suspected as environmental disease triggers, but none of them has consistently been incriminated, and it is unclear how so many different infections may play a role. We show that a microbial peptide, common to several major classes of bacteria, can induce MS-like disease in humanized mice by crossreacting with a T cell receptor (TCR) that also recognizes a peptide from myelin basic protein, a candidate MS autoantigen. Structural analysis demonstrates this crossreactivity is due to structural mimicry of a binding hotspot shared by self and microbial antigens, rather than to degenerate TCR recognition. Biophysical studies reveal that the autoreactive TCR binding affinity is markedly lower for the microbial (mimicry) peptide than for the autoantigenic peptide. Thus, these data suggest a possible explanation for the difficulty in incriminating individual infections in the development of MS.

DOI10.1016/j.immuni.2009.01.009
Alternate JournalImmunity
PubMed ID19303388
Grant ListMC_U137881016 / / Medical Research Council / United Kingdom
/ / Medical Research Council / United Kingdom
G0500365 / / Medical Research Council / United Kingdom
G9722488 / / Medical Research Council / United Kingdom
G9900061 / / Medical Research Council / United Kingdom
Publication institute
Other